• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Five modifiable risk factors contribute to cardiovascular disease and mortality

byDavid XiangandKiera Liblik
December 11, 2023
in Cardiology, Chronic Disease, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, five risk factors (body mass index, systolic blood pressure, non–high-density lipoprotein cholesterol, current smoking, and diabetes) contributed to increased incidence of cardiovascular disease. 

2. These factors were also noted to increase the risk of death from any cause.

Evidence Rating Level: 2 (Good)

Study Rundown: Modifiable risk factors such as body mass index, systolic blood pressure, non–high-density lipoprotein cholesterol, smoking status, and diabetes have been used to derive contemporary risk scores for the estimation of the 10-year risk of cardiovascular disease, though they are given different weights. However, there is a gap in knowledge as to understanding the region- and sex-specific associations of these cardiovascular risk factors with the development of cardiovascular disease, which can ultimately help reduce the burden of cardiovascular disease and death from any cause for persons and populations. Overall, this study found that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. This study was limited by residual confounding and the categorization of geographic regions being defined by the World Health Organization, whereas different categorization schemas may produce different results. Nevertheless, these study’s findings are significant, as they demonstrate that these five modifiable risk factors are strongly associated with incident cardiovascular disease and death from any cause.

Click to read the study in NEJM

In-Depth [retrospective cohort study]: This retrospective cohort study utilized patient-level data from 112 cohort studies conducted in 34 countries and eight geographic regions participating in the Global Cardiovascular Risk Consortium. Patients who were included in the prior studies were eligible for the study, whereas patients excluded from the prior studies were excluded from this study. Five risk factors (body mass index, systolic blood pressure, non-HDL cholesterol, current smoking status, and diabetes) and two primary outcomes (cardiovascular disease and death from any cause) were assessed in the study because of the heterogeneity of the effects of the risk factors on outcomes and the widespread availability of these data in the population. Outcomes in the primary analysis were assessed via a two-stage, multivariate, random effects meta-analysis of individual participant data. Based on the primary analysis, 80,596 participants experienced incident cardiovascular disease after a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants experienced death after a median follow-up of 8.7 years (maximum, 47.6). The aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% Confidence Interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men after accounting for all 5 risk factors. Furthermore, the 10-year all-cause mortality was 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6) for women and men, respectively. Overall, this study showed that these five modifiable risk factors are strongly associated with cardiovascular disease and death from any cause among men and women.

RELATED REPORTS

AI-Powered Stethoscope Could Diagnose Heart Disease in Minutes

Patients with varicose veins may be at an increased risk of dementia

2 Minute Medicine Rewind May 5, 2025

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: body mass indexcardiologycardiovascular diseasechronic diseasecurrent smokingdiabetesnon–high-density lipoprotein cholesterolpublic healthsystolic blood pressure
Previous Post

Tiragolumab With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage SCLC

Next Post

Several nutrients may be associated with improved cognitive function later in life

RelatedReports

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain
AI Roundup

AI-Powered Stethoscope Could Diagnose Heart Disease in Minutes

May 7, 2025
Cardiology

Patients with varicose veins may be at an increased risk of dementia

May 5, 2025
UTI associated with increased risk of preeclampsia
Weekly Rewinds

2 Minute Medicine Rewind May 5, 2025

May 5, 2025
Parental cannabis use increasing, cigarette use decreasing
Psychiatry

Cannabis use frequency increased following legalization with a decrease in misuse observed

May 2, 2025
Next Post
Poor olfaction linked to increased mortality in older adults

Several nutrients may be associated with improved cognitive function later in life

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Curbing Cravings with Zepbound, Tales of Transplants, New Gonorrhea Treatment, and Preterm Problems

#VisualAbstract: Early endovascular thrombectomy improves functional outcomes in large infarct ischaemic stroke

#VisualAbstract: Early endovascular thrombectomy improves functional outcomes in large infarct ischaemic stroke

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike
  • AI-Powered Stethoscope Could Diagnose Heart Disease in Minutes
  • #VisualAbstract: DPP-1 Inhibitor Brensocatib Improves Outcomes in Bronchiectasis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.